Table 1 Baseline data and post-Ramadan outcomes for the 2 studied groups

Sex

 Female

56 (98.2%)

84 (92.3%)

χ² = 2.417

^FEp=

0.153

 Male

1 (1.8%)

7 (7.7%)

Age (years)

 Mean ± SD.

37.32 ± 11.01

46.97 ± 13.85

t = 4.691^*

< 0.001^*

 Median (Min. – Max.)

37 (18–60)

45 (17–78)

Diagnosis

 HT

44 (77.2%)

62 (68.1%)

χ²=

6.901

^FEp=

0.084

 Tx

6 (10.5%)

23 (25.3%)

 RAI

5 (8.8%)

5 (5.5%)

 PPT

1 (1.8%)

1 (1.1%)

 Unclassified

1 (1.8%)

0 (0%)

Regimen number

 1

37 (64.9%)

32 (35.2%)

χ²=

16.689^*

^MCp=

0.001^*

 2

17 (29.8%)

41 (45.1%)

 3

3 (5.3%)

7 (7.7%)

 4

0 (0%)

11(12.1)

Adherence

 Adherent

55 (96.5%)

81 (89%)

χ² = 2.632

^FEp=

0.130

 Non-adherent

2 (3.5%)

10 (11%)

Pre-Ramadan TSH

 Mean ± SD.

1.80 ± 0.88

1.39 ± 0.72

U = 1850.5^*

0.003^*

 Median (Min. – Max.)

1.81 (0.30–3.90)

1.17 (0.30–3.68)

Post-Ramadan TSH

 Mean ± SD.

2.30 ± 1.25

1.69 ± 1.70

U = 1653.5^*

< 0.001^*

 Median (Min. – Max.)

2.08 (0.08–7.50)

1.52 (0.08–15.1)

Post-Ramadan Thyroid status

 Euthyroid

52 (91.2%)

86 (94.5%)

χ² = 0.598

^FEp=

0.509

 Dysthyroid

5 (8.8%)

5 (5.5%)